BLOOD BIOMARKERS in PAEDIATRIC MTBI

Launched by PEDIATRIC CLINICAL RESEARCH PLATFORM · Jan 30, 2024

Keywords

ClinConnect Summary

The t-BIOMAP study is looking to improve how we care for children with mild traumatic brain injuries (mTBI) by examining blood samples for specific markers. These markers could help doctors decide whether a child needs a CT scan, which is a type of imaging test that can expose them to radiation. By identifying these markers, the study hopes to shorten the time children spend in the emergency department and predict if they will experience symptoms after their injury, like headaches or dizziness.

To participate in this study, children aged 0 to 17 who come to the emergency department within 24 hours of a mild TBI might be eligible. During the study, a blood sample will be taken, and families will complete a questionnaire about their child's symptoms two weeks and three months after the injury. This research is important as it aims to find safer and more efficient ways to manage mild TBIs in kids.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • mTBI within 24 hours
• Exclusion Criteria:
• • refusal of child or parents
• • evidence of intoxication with alcohol or other substances
• • history of TBI ( less than one month)
• • epilepsy, encephalitis, meningitis, melanoma